(Q27025300)
Statements
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges (English)
0 references
8 July 2013
10 references
3 April 2019
25 June 2019
31 July 2019
19 September 2019
12 October 2019
18 October 2019
15 December 2019
1 August 2020
8 February 2021
10 references
3 April 2019
25 June 2019
31 July 2019
19 September 2019
12 October 2019
18 October 2019
15 December 2019
1 August 2020
8 February 2021
9 references
3 April 2019
25 June 2019
31 July 2019
19 September 2019
12 October 2019
18 October 2019
15 December 2019
1 August 2020
8 February 2021
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference